Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown. We previously determined, first, that metabolic endotoxemia controls the inflammatory tone, body weight gain, and diabetes, and second, that high-fat feeding modulates gut microbiota and the plasma concentration of lipopolysaccharide (LPS), i.e., metabolic endotoxemia. Therefore, it remained to demonstrate whether changes in gut microbiota control the occurrence of metabolic diseases. RESEARCH DESIGN AND METHODS—We changed gut microbiota by means of antibiotic treatment to demonstrate, first, that changes in gut microbiota could be responsible for the control of metabolic endotoxemia, the low-grade inflammation, obesity, and type 2 diabetes and, second, to provide some mechanisms responsible for such effect. RESULTS—We found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat–fed and ob/ob mice. This effect was correlated with reduced glucose intolerance, body weight gain, fat mass development, lower inflammation, oxidative stress, and macrophage infiltration marker mRNA expression in visceral adipose tissue. Importantly, high-fat feeding strongly increased intestinal permeability and reduced the expression of genes coding for proteins of the tight junctions. Furthermore, the absence of CD14 in ob/ob CD14−/− mutant mice mimicked the metabolic and inflammatory effects of antibiotics. CONCLUSIONS—This new finding demonstrates that changes in gut microbiota controls metabolic endotoxemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability. It would thus be useful to develop strategies for changing gut microbiota to control, intestinal permeability, metabolic endotoxemia, and associated disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacterial translocation can be defined as the passage of bacteria, or bacterial products such as LPS, into the portal circulation and happens when the complex regulation of the mechanisms of the gut barrier is lost [276], which has been linked with the occurrence of NAFLD, NASH, hepatic fibrosis, and HCC in several rodent models [227,228,277].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [276]
In the citing paper
“Penetration of lipopolysaccharide into the bloodstream is controlled by the integrity of the gut barrier.”
From Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice (2016) · cites this paper as [48]
In the citing paper
“In obese rodents, antibiotics and prebiotics were able to restore gut barrier integrity and metabolic functions, providing evidence for the gut barrier as a mediator of microbiota-induced systemic inflammation [98,99].”
Citations
Cites
1 retracted
Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A., et al. (2007) · Diabetes · doi:10.2337/db06-1595 · Cited by 826 · cited 3×
“We and others have recently demonstrated that the mechanisms of highfat diet-induced inflammation and metabolic disorders were clearly linked to LPS (4;24-28).”
BackgroundResultRetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 7×
“Inflammation: PAI-1, IL-1, and TNF- mRNA concentrations (A, D and G); oxidative stress: STAMP-2 and NADPHox mRNA concentrations (B and E); macrophage infiltration markers: MCP-1 and F4/80 mRNA concentrations (C and F) in mice fed normal diet (CT), normal diet and antibiotics (CT-Ab), high-fat diet (HF), or high-fat di…”
ResultInfluentialInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown (2,3).”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 2×
“Gut microbiota has recently been proposed as an environmental factor involved in the control of body weight and energy homeostasis (7-12).”
BackgroundResultMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 16×
“Although the reasons for its increase in plasma during high-fat feeding were undetermined, its levels were closely correlated but not causatively demonstrated, with changes in intestinal microbiota where the Gram negative–to–Gram positive ratio increased during high-fat feeding (4).”
BackgroundMethodResultSelf-citationThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Germ-free mice of the same age and genetic background as conventional mice fed with a normal chow diet had a 40% lower weight (11), whereas germ-free mice colonized with the gut microbiota derived from the conventional mice increased their fat mass and developed insulin resistance within 2 weeks.”
BackgroundObesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“These animals are characterized by different gut microbiota (8,12), higher inflammatory tone, and endotoxemia when compared with wild-type mice (23).”
BackgroundIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“Oxidative stress is frequently associated with inflammation and metabolic dysfunction in adipose depots (20-22).”
BackgroundMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Diabetes 57:1470–1481, 2008 Environmental factors, such as a fat-enriched diet and a sedentary lifestyle, are the causes of the great prevalence of obesity and type 2 diabetes in the population (1).”
Background
Cited by
Items 501–600 of 1,065
The role of the gut microbiota in metabolic health
Janssen, A. W. F., & Kersten, S. (2015) · The FASEB Journal · doi:10.1096/fj.14-269514 · Cited by 197
Luo, Y., Chen, G.-L., Hannemann, N., Ipseiz, N., Krönke, G., Bäuerle, T., Munos, L., Wirtz, S., Schett, G., & Bozec, A. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.020 · Cited by 198
“This finding adds an important role of the microbiota, linking obesity to diseases such as type 2 diabetes (Cani et al., 2008), asthma, and inflammatory bowel diseases (Hart and Hendy, 2014).”
BackgroundMicrobiota in T-cell homeostasis and inflammatory diseases
Lee, N., & Kim, W.-U. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.36 · Cited by 198
Gut microbiota in overweight and obesity: crosstalk with adipose tissue
Cani, P. D., & Van Hul, M. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00867-z · Cited by 194
“In addition, the gut microbiota has been shown to regulate the development and function of adipose tissue in mice 76–78 .”
Self-citationGut microbiome and metabolic syndrome
Mazidi, M., Rezaie, P., Kengne, A. P., Mobarhan, M. G., & Ferns, G. A. (2016) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2016.01.024 · Cited by 196
Nonalcoholic fatty liver disease: Evolving paradigms
Lonardo, A., Nascimbeni, F., Maurantonio, M., Marrazzo, A., Rinaldi, L., & Adinolfi, L. E. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6571 · Cited by 197
Innate sensors of pathogen and stress: Linking inflammation to obesity
Jin, C., & Flavell, R. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.06.022 · Cited by 196
Liu, J., He, Z., Ma, N., & Chen, Z.-Y. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b06817 · Cited by 195
Lai, Z.-L., Tseng, C.-H., Ho, H. J., Cheung, C. K. Y., Lin, J.-Y., Chen, Y.-J., Cheng, F.-C., Hsu, Y.-C., Lin, J.-T., El-Omar, E. M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33893-y · Cited by 192
On phagocytes and macular degeneration
Guillonneau, X., Eandi, C. M., Paques, M., Sahel, J.-A., Sapieha, P., & Sennlaub, F. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.06.002 · Cited by 185
“digestion, dietary metabolism and endotoxemia, they ar prime candidates to impact chronic low-grade inflammation (Cani et al., 2008; Spanogia nnopoulos et al., 2016) such as that”
BackgroundAdipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes
Massier, L., Chakaroun, R., Tabei, S., Crane, A., Didt, K. D., Fallmann, J., von Bergen, M., Haange, S.-B., Heyne, H., Stumvoll, M., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320118 · Cited by 194
Heiss, G., Snyder, M. L., Teng, Y., Schneiderman, N., Llabre, M. M., Cowie, C., Carnethon, M., Kaplan, R., Giachello, A., Gallo, L., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2505 · Cited by 192
“Development of the metabolic syndrome in humans is also thought to be promoted by high levels of saturated fats, supported by animal models where high-fat diets induced metabolic disease (38).”
BackgroundObesity, airway hyperresponsiveness, and inflammation
Shore, S. A. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00749.2009 · Cited by 194
Wu, K. L., Chan, S. H., & Chan, J. Y. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-212 · Cited by 194
“In contrast to high-dose endotoxin that induces a robust yet transient inflammatory response, low-dose endotoxin causes low-grade yet persistent inflammatory responses from the host, as reflected in the mildly sustained levels of inflammatory mediators [33,34].”
BackgroundAdiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions
Murphy, N., Jenab, M., & Gunter, M. J. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0038-1 · Cited by 194
SUN, S.-S., WANG, K., MA, K., BAO, L., & LIU, H.-W. (2019) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(19)30003-2 · Cited by 194
“Previous studies have indicated that obesity-induced gut dysbiosis impairs intestinal integrity, leading to the release of LPS into blood ([39-40]).”
Backgroundde Souza, E. L., de Albuquerque, T. M. R., dos Santos, A. S., Massa, N. M. L., & de Brito Alves, J. L. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1425285 · Cited by 193
“Modulation of the intestinal microbiota by high-fat diets has negatively impacted the intestinal permeability and expression of genes encoding proteins, such as those exerting an important role in intestinal barrier function (Cani et al. 2008; Kim et al. 2012).”
BackgroundIntestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
Saltzman, E. T., Palacios, T., Thomsen, M., & Vitetta, L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00061 · Cited by 193
“The prevalence of NAFLD in obese adults or those with T2DM has been reported to be 67.5 and 74%, respectively, (Williams et al., 2011; Paquissi, 2016) compared to only 25% in the general adult population (Younossi et al., 2016).”
BackgroundInfluentialAnthocyanins as inflammatory modulators and the role of the gut microbiota
Morais, C. A., de Rosso, V. V., Estadella, D., & Pisani, L. P. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.11.008 · Cited by 191
“Orlando et al. also reported that the administration of L. rhamnosus in cell culture was able to restore paracellular permeability, affecting the expression of different TJ proteins, particularly ZO-1 [58].”
BackgroundInfluentialLyu, M., Wang, Y.-F., Fan, G.-W., Wang, X.-Y., Xu, S.-Y., & Zhu, Y. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02146 · Cited by 192
“Metabolic characteristics of obesity and T2D in mice were not initiated by injecting LPS when CD14/TLR4 receptor was genetically deleted, showing the significant contribution of LPS/CD14/TLR4 signaling (Shi et al., 2006; Cani et al., 2007, 2008; Poggi et al., 2007).”
BackgroundProbiotics: How Effective Are They in the Fight against Obesity?
Mazloom, K., Siddiqi, I., & Covasa, M. (2019) · Nutrients · doi:10.3390/nu11020258 · Cited by 192
Crosstalk between the microbiota-gut-brain axis and depression
Du, Y., Gao, X.-R., Peng, L., & Ge, J.-F. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04097 · Cited by 191
“The endotoxins produced by bacteria known as LPS would lead to inflammation [115, 116, 117, 118].”
BackgroundThe Gut Microbiota and Liver Disease
Llorente, C., & Schnabl, B. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.04.003 · Cited by 190
Denou, E., Lolmède, K., Garidou, L., Pomie, C., Chabo, C., Lau, T. C., Fullerton, M. D., Nigro, G., Zakaroff‐Girard, A., Luche, E., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404169 · Cited by 191
“…metabolic endotoxemia during obesity and that bacterial factors from the gut, such as lipopolysaccharide (LPS), accumulated in the blood and contributed to inflammation and insulin intolerance through CD14/TLR4 pathogen-sensing systems (Cani et al, 2007, 2008; Poggi et al, 2007; Luche et al, 2013).”
BackgroundSelf-citationGut microbiota and immune crosstalk in metabolic disease
Burcelin, R. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.016 · Cited by 191
“As discussed above, high-fat diet induces impaired gut permeability [68] through mechanisms impairing the expression of genes that the proteins ensure a tight junction of epithelial cells [6].”
BackgroundSelf-citationProtective Microbiota: From Localized to Long-Reaching Co-Immunity
Chiu, L., Bazin, T., Truchetet, M.-E., Schaeverbeke, T., Delhaes, L., & Pradeu, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01678 · Cited by 190
Chen, G., Xie, M., Dai, Z., Wan, P., Ye, H., Zeng, X., & Sun, Y. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700485 · Cited by 190
Type I Interferon Responses Drive Intrahepatic T Cells to Promote Metabolic Syndrome
Ghazarian, M., Revelo, X. S., Nøhr, M. K., Luck, H., Zeng, K., Lei, H., Tsai, S., Schroer, S. A., Park, Y. J., Chng, M. H. Y., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aai7616 · Cited by 190
“IFN-I responses are typically induced by RNA or DNA viruses through the endosomal TLR7/TLR8/TLR9 but can also be stimulated through other TLRs, including TLR4 (23, 44).”
BackgroundInfluentialLuca, M., Di Mauro, M., Di Mauro, M., & Luca, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4730539 · Cited by 190
“As stated above in the sections dedicated to AD, depression, and diabetes, several studies have reported the usefulness of microbiota manipulation in the treatment of these disorders [61, 91, 115].”
BackgroundParnell, J. A., Raman, M., Rioux, K. P., & Reimer, R. A. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02730.x · Cited by 189
“A link between the gut microbiota and metabolic endotoxemia is further corroborated by the observation that antibiotic treatment reduces metabolic endotoxemia (29).”
ResultWang, Y., Chun, O., & Song, W. (2013) · Nutrients · doi:10.3390/nu5082969 · Cited by 190
“Human gut microbiota composition has been found to be associated with obesity and inflammation [160,161].”
BackgroundGuerville, M., & Boudry, G. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00098.2016 · Cited by 189
“Some studies suggest that the paracellular pathway might be involved in LPS transport, based on the parallel increase in plasma LPS and in vivo permeability to fluorescently tagged dextran 4000 in models of obesity (22).”
BackgroundHarnessing Gut Microbes for Mental Health: Getting From Here to There
Bruce-Keller, A. J., Salbaum, J. M., & Berthoud, H.-R. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.014 · Cited by 189
Gut Microbiome and Antibiotics
Iizumi, T., Battaglia, T., Ruiz, V., & Perez Perez, G. I. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.11.004 · Cited by 187
Frost, F., Kacprowski, T., Rühlemann, M., Pietzner, M., Bang, C., Franke, A., Nauck, M., Völker, U., Völzke, H., Dörr, M., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322753 · Cited by 187
“38 Hence, the microbial instability may predispose to further increases in LPS secretion activity which in turn can aggravate the metabolic disorders in a vicious circle.”
Causality of small and large intestinal microbiota in weight regulation and insulin resistance
Scheithauer, T. P. M., Dallinga-Thie, G. M., de Vos, W. M., Nieuwdorp, M., & van Raalte, D. H. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.002 · Cited by 188
Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders
Rastelli, M., Knauf, C., & Cani, P. D. (2018) · Obesity · doi:10.1002/oby.22175 · Cited by 187
“, toll-like receptor [TLR] knockout mice [CD14 or TLR-4]), it was unequivocally demonstrated that LPS was a triggering factor involved in the onset of inflammation and eventually insulin resistance, possibly by altering the mechanisms of food intake regulation and fat mass development (18,97-99).”
BackgroundSelf-citationGenser, L., Aguanno, D., Soula, H. A., Dong, L., Trystram, L., Assmann, K., Salem, J., Vaillant, J., Oppert, J., Laugerette, F., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5134 · Cited by 187
“Among the large repertoire of tight junction proteins, our study focused on tricellulin and occludin, two proteins involved in the barrier to macromolecules [34,35], the latter being found decreased in rodent models of genetic- or diet-induced obesity [11,36,37].”
BackgroundResultInfluentialMiyaoka, T., Kanayama, M., Wake, R., Hashioka, S., Hayashida, M., Nagahama, M., Okazaki, S., Yamashita, S., Miura, S., Miki, H., et al. (2018) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000299 · Cited by 186
Role of Adiposity-Driven Inflammation in Depressive Morbidity
Capuron, L., Lasselin, J., & Castanon, N. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.123 · Cited by 182
“…Neuropsychopharmacology REVIEWS individuals (Capuron et al, 2011b; Park et al, 2005; Visser et al, 1999) and animal models of obesity (Cani et al, 2008; De Souza et al, 2005; Dinel et al, 2011, 2014; Lawrence et al, 2012; Pistell et al, 2010; Xu et al, 2003).”
BackgroundInfluentialJašarević, E., Howard, C. D., Morrison, K., Misic, A., Weinkopff, T., Scott, P., Hunter, C., Beiting, D., & Bale, T. L. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0182-5 · Cited by 189
Ba, Q., Li, M., Chen, P., Huang, C., Duan, X., Lu, L., Li, J., Chu, R., Xie, D., Song, H., et al. (2017) · Environmental Health Perspectives · doi:10.1289/ehp360 · Cited by 186
Balakumar, M., Prabhu, D., Sathishkumar, C., Prabu, P., Rokana, N., Kumar, R., Raghavan, S., Soundarajan, A., Grover, S., Batish, V. K., et al. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1317-7 · Cited by 187
Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability
Ramos Meyers, G., Samouda, H., & Bohn, T. (2022) · Nutrients · doi:10.3390/nu14245361 · Cited by 184
Milk Intolerance, Beta-Casein and Lactose
Pal, S., Woodford, K., Kukuljan, S., & Ho, S. (2015) · Nutrients · doi:10.3390/nu7095339 · Cited by 184
“The second is that colonic inflammation affects the processing of malabsorbed lactose, possibly via changes in the gut microbiota that occur with gut inflammation [59].”
BackgroundLaugerette, F., Furet, J.-P., Debard, C., Daira, P., Loizon, E., Géloën, A., Soulage, C. O., Simonet, C., Lefils-Lacourtablaise, J., Bernoud-Hubac, N., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2011 · Cited by 186
“In this respect, recent studies have shown that rodents fed a high-fat diet display alterations of gut microbiota that increase intestinal permeability (10) and gut inflammation (6).”
BackgroundClarke, R., Dordevic, A., Tan, S., Ryan, L., & Coughlan, M. (2016) · Nutrients · doi:10.3390/nu8030125 · Cited by 186
“As changes in microbiota composition are associated with increases in systemic inflammation [36,37] it is possible that the dietary AGEs which escape absorption may also trigger inflammation via this mechanism.”
BackgroundMeat, dairy and plant proteins alter bacterial composition of rat gut bacteria
Zhu, Y., Lin, X., Zhao, F., Shi, X., Li, H., Li, Y., Zhu, W., Xu, X., Li, C., & Zhou, G. (2015) · Scientific Reports · doi:10.1038/srep15220 · Cited by 186
“A greater abundance of Lactobacillus may reduce the antigen load from gut bacteria to the host, and may alleviate certain inflammation responses and metabolic syndromes 22–25 .”
The germ-organ theory of non-communicable diseases
Byndloss, M. X., & Bäumler, A. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.158 · Cited by 186
Gut microbiota: a key player in health and disease. A review focused on obesity
Villanueva-Millán, M. J., Pérez-Matute, P., & Oteo, J. A. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0390-3 · Cited by 186
“3 Suggested mechanisms that link the changes observed in gut microbiota composition and the inflammation associated with the onset of obesity and associated disorders (modified from [18, 19]) 520 M.”
BackgroundGori, A., Rizzardini, G., van't Land, B., Amor, K. B., van Schaik, J., Torti, C., Quirino, T., Tincati, C., Bandera, A., Knol, J., et al. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.15 · Cited by 185
Lack of soluble fiber drives diet-induced adiposity in mice
Chassaing, B., Miles-Brown, J., Pellizzon, M., Ulman, E., Ricci, M., Zhang, L., Patterson, A. D., Vijay-Kumar, M., & Gewirtz, A. T. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00172.2015 · Cited by 183
“In support of this notion, DIO can be ameliorated in germ-free mice, by antibiotic treatment, or by absence of Toll-like receptor (TLR)-4 (3, 6, 22).”
BackgroundZhang, X., Fang, Z., Zhang, C., Xia, H., Jie, Z., Han, X., Chen, Y., & Ji, L. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0226-y · Cited by 184
“significantly and positively correlated with improved glucose tolerance, insulin secretion, decreased endotoxemia, and proinflammatory cytokine level [9].”
BackgroundLeite, A. Z., Rodrigues, N. D. C., Gonzaga, M. I., Paiolo, J. C. C., de Souza, C. A., Stefanutto, N. A. V., Omori, W. P., Pinheiro, D. G., Brisotti, J. L., Matheucci Junior, E., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01107 · Cited by 185
Kong, H., Zhao, H., Chen, T., Song, Y., & Cui, Y. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04786-w · Cited by 180
“In DR, complex microbial systems result in high LPS levels in the serum [18].”
Gorecki, A. M., Preskey, L., Bakeberg, M. C., Kenna, J. E., Gildenhuys, C., MacDougall, G., Dunlop, S. A., Mastaglia, F. L., Akkari, P. A., Koengten, F., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00839 · Cited by 184
Do Interactions Between Gut Ecology and Environmental Chemicals Contribute to Obesity and Diabetes?
Snedeker, S. M., & Hay, A. G. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104204 · Cited by 184
Sellmann, C., Priebs, J., Landmann, M., Degen, C., Engstler, A. J., Jin, C. J., Gärttner, S., Spruss, A., Huber, O., & Bergheim, I. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.05.011 · Cited by 184
The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis
Geng, S., Chen, K., Yuan, R., Peng, L., Maitra, U., Diao, N., Chen, C., Zhang, Y., Hu, Y., Qi, C.-F., et al. (2016) · Nature Communications · doi:10.1038/ncomms13436 · Cited by 184
A review of dietary and microbial connections to depression, anxiety, and stress
Taylor, A. M., & Holscher, H. D. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1493808 · Cited by 183
Beneficial Effect of Intestinal Fermentation of Natural Polysaccharides
Zhang, T., Yang, Y., Liang, Y., Jiao, X., & Zhao, C. (2018) · Nutrients · doi:10.3390/nu10081055 · Cited by 184
“Antibiotic-induced changes of gut microbiota can reduce metabolic endotoxemia and cecal lipopolysaccharide so as to improve metabolic parameters in both high-fat-fed and ob/ob mice [90].”
BackgroundContribution of Gut Bacteria to Liver Pathobiology
Son, G., Kremer, M., & Hines, I. N. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/453563 · Cited by 183
“[85] P.”
BackgroundGut microbiota and probiotics in chronic liver diseases
Cesaro, C., Tiso, A., Del Prete, A., Cariello, R., Tuccillo, C., Cotticelli, G., del Vecchio Blanco, C., & Loguercio, C. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.10.015 · Cited by 182
Schepper, J. D., Collins, F. L., Rios-Arce, N. D., Raehtz, S., Schaefer, L., Gardinier, J. D., Britton, R. A., Parameswaran, N., & McCabe, L. R. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3635 · Cited by 182
Musso, G., Gambino, R., & Cassader, M. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283347ebb · Cited by 182
The gut microbiota as a novel regulator of cardiovascular function and disease
Battson, M. L., Lee, D. M., Weir, T. L., & Gentile, C. L. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.12.010 · Cited by 183
Inulin-type fructan improves diabetic phenotype and gut microbiota profiles in rats
Zhang, Q., Yu, H., Xiao, X., Hu, L., Xin, F., & Yu, X. (2018) · PeerJ · doi:10.7717/peerj.4446 · Cited by 182
“LPS can activate pro-inflammatory cytokine production, leading to impaired insulin sensitivity and induction of insulin resistance-related metabolic disorders (Cani et al., 2008).”
BackgroundRole of Personalized Nutrition in Chronic-Degenerative Diseases
Di Renzo, L., Gualtieri, P., Romano, L., Marrone, G., Noce, A., Pujia, A., Perrone, M. A., Aiello, V., Colica, C., & De Lorenzo, A. (2019) · Nutrients · doi:10.3390/nu11081707 · Cited by 181
“Consumption of saturated fat increases insulin resistance and white adipose tissue (WAT) inflammation [156].”
BackgroundReview article: the future of microbiome‐based therapeutics
Gulliver, E. L., Young, R. B., Chonwerawong, M., D'Adamo, G. L., Thomason, T., Widdop, J. T., Rutten, E. L., Rossetto Marcelino, V., Bryant, R. V., Costello, S. P., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17049 · Cited by 180
Castanon, N., Luheshi, G., & Layé, S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00229 · Cited by 181
Milk sphingomyelin improves lipid metabolism and alters gut microbiota in high fat diet-fed mice
Norris, G. H., Jiang, C., Ryan, J., Porter, C. M., & Blesso, C. N. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.12.003 · Cited by 182
“Serum LPS can be influenced by differences in gut microbiota [8], chylomicron production [6], and differences in gut permeability [7].”
Dietary silver nanoparticles can disturb the gut microbiota in mice
van den Brule, S., Ambroise, J., Lecloux, H., Levard, C., Soulas, R., De Temmerman, P.-J., Palmai-Pallag, M., Marbaix, E., & Lison, D. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0149-1 · Cited by 179
“order (that includes Bacteroides genera decreased here) [28, 59].”
BackgroundThe role of diet and intestinal microbiota in the development of metabolic syndrome
Santos-Marcos, J. A., Perez-Jimenez, F., & Camargo, A. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.03.017 · Cited by 180
Lakkis, J. I., & Weir, M. R. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.07.005 · Cited by 177
Pu-erh tea ameliorates obesity and modulates gut microbiota in high fat diet fed mice
Ye, J., Zhao, Y., Chen, X., Zhou, H., Yang, Y., Zhang, X., Huang, Y., Zhang, N., Lui, E. M. K., & Xiao, M. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110360 · Cited by 178
Schwartz, E. A., Zhang, W.-Y., Karnik, S. K., Borwege, S., Anand, V. R., Laine, P. S., Su, Y., & Reaven, P. D. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.201681 · Cited by 179
Gut microbiome, endocrine control of gut barrier function and metabolic diseases
Régnier, M., Van Hul, M., Knauf, C., & Cani, P. D. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0473 · Cited by 179
Self-citationEffects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
Zhang, Q., & Hu, N. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s286430 · Cited by 179
“High-fat diet could alter the composition of the gut microbiota in mice and increase the concentration of LPS in mouse plasma, leading to intestinal permeability changes and impaired glucose tolerance.(13) Changes in the gut microbiota under metabolic disease conditions can downregulate connexins and claudins in intes…”
BackgroundIntestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective
Han, J.-L., & Lin, H.-L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17737 · Cited by 179
High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction
Rastmanesh, R. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.10.002 · Cited by 178
“Other experiments using antibiotics obtained similar results [85,86,88].”
BackgroundResultNagata, N., Xu, L., Kohno, S., Ushida, Y., Aoki, Y., Umeda, R., Fuke, N., Zhuge, F., Ni, Y., Nagashimada, M., et al. (2017) · Diabetes · doi:10.2337/db16-0662 · Cited by 177
“Although a number of pharmacological treatments for obesity and NAFLD have been tested, few drugs are clinically available owing to the lack of long-term efficacy and safety concerns (3,4).”
BackgroundResultInfluentialGut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns
Del Chierico, F., Abbatini, F., Russo, A., Quagliariello, A., Reddel, S., Capoccia, D., Caccamo, R., Ginanni Corradini, S., Nobili, V., De Peppo, F., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01210 · Cited by 177
“Indeed, modulation of the gut microbiota by consumption of fiber, antibiotic treatment or fecal transplantation can have positive effects on inflammation and insulin sensitivity (Robertson et al., 2005; Cani et al., 2008).”
BackgroundYang, Y., Zhong, Z., Wang, B., Xia, X., Yao, W., Huang, L., Wang, Y., & Ding, W. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0437-1 · Cited by 178
Fatty acid overproduction by gut commensal microbiota exacerbates obesity
Takeuchi, T., Kameyama, K., Miyauchi, E., Nakanishi, Y., Kanaya, T., Fujii, T., Kato, T., Sasaki, T., Tachibana, N., Negishi, H., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.12.013 · Cited by 178
Santos-Marcos, J. A., Mora-Ortiz, M., Tena-Sempere, M., Lopez-Miranda, J., & Camargo, A. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00490-2 · Cited by 176
“In fact, a growing body of scientific evidence indicates that the interaction between the gut microbiota and its host is key to the development of metabolic diseases [25].”
BackgroundThe epithelial barrier theory and its associated diseases
Sun, N., Ogulur, I., Mitamura, Y., Yazici, D., Pat, Y., Bu, X., Li, M., Zhu, X., Babayev, H., Ardicli, S., et al. (2024) · Allergy · doi:10.1111/all.16318 · Cited by 173
Lim, S.-M., Jeong, J.-J., Woo, K. H., Han, M. J., & Kim, D.-H. (2016) · Nutrition Research · doi:10.1016/j.nutres.2015.12.001 · Cited by 176
“well as ours reported an HFD-dependent increase in lipopolysaccharide (LPS) production by gut microbiota or endotoxemia [9–11].”
BackgroundInfluentialMannose Alters Gut Microbiome, Prevents Diet-Induced Obesity, and Improves Host Metabolism
Sharma, V., Smolin, J., Nayak, J., Ayala, J. E., Scott, D. A., Peterson, S. N., & Freeze, H. H. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.064 · Cited by 176
Li, L.-L., Wang, Y.-T., Zhu, L.-M., Liu, Z.-Y., Ye, C.-Q., & Qin, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-58048-w · Cited by 174
The Role of the Gut Microbiota in the Pathogenesis of Diabetes
Bielka, W., Przezak, A., & Pawlik, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010480 · Cited by 176
Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target
Wang, K., Zhang, Z., Hang, J., Liu, J., Guo, F., Ding, Y., Li, M., Nie, Q., Lin, J., Zhuo, Y., et al. (2023) · Science · doi:10.1126/science.add5787 · Cited by 173
“(E) Activity of hDPP4 and nine active microbial DPP4 homologs against GLP-1(7-37), n = 3 biological replicates per group.”
BackgroundInfluentialAnhê, F. F., Varin, T. V., Le Barz, M., Desjardins, Y., Levy, E., Roy, D., & Marette, A. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0172-9 · Cited by 175
Talking microbes: When gut bacteria interact with diet and host organs
Cani, P. D., & Everard, A. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500406 · Cited by 176
“For example, we discovered that dietary fatty acids increase gut permeability, thereby leading to the translocation of intestinal luminal factors [22,65].”
BackgroundSelf-citationYeung, C.-Y., Chan, W.-T., Jiang, C.-B., Cheng, M.-L., Liu, C.-Y., Chang, S.-W., Chiang Chiau, J.-S., & Lee, H.-C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138746 · Cited by 176
“Cytokines, including TNF-α, IL-1β and IL-6, were detected by the Maxima SYBR Green/ROX Q-PCR Master Mix (Applied Biosystems, Warrington, UK), with 100 nM of each of the forward and reverse primers and 1 ng DNA per reaction.”
MethodInfluentialMetabolic endotoxemia is dictated by the type of lipopolysaccharide
Anhê, F. F., Barra, N. G., Cavallari, J. F., Henriksbo, B. D., & Schertzer, J. D. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109691 · Cited by 175
Dehghan, P., Gargari, B. P., Jafar-Abadi, M. A., & Aliasgharzadeh, A. (2014) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2013.836738 · Cited by 176
“It is known that LPS is an initiator of metabolic impairment in obesity and type 2 diabetes (Cani et al., 2008).”
BackgroundInfluentialSingh, V., Chassaing, B., Zhang, L., San Yeoh, B., Xiao, X., Kumar, M., Baker, M. T., Cai, J., Walker, R., Borkowski, K., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.028 · Cited by 175
“Potential mechanisms by which the microbiota influences host metabolism include increased calorie extraction (Ley et al., 2006; Turnbaugh et al., 2006), metabolic endotoxemia (Cani et al., 2008), and generation of toxic metabolites (Wang et al., 2011).”
BackgroundZhu, Z., Zhu, B., Sun, Y., Ai, C., Wang, L., Wen, C., Yang, J., Song, S., & Liu, X. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800446 · Cited by 174
van der Weerd, K., Dik, W. A., Schrijver, B., Schweitzer, D. H., Langerak, A. W., Drexhage, H. A., Kiewiet, R. M., van Aken, M. O., van Huisstede, A., van Dongen, J. J. M., et al. (2012) · Diabetes · doi:10.2337/db11-1065 · Cited by 174
Scheffler, L., Crane, A., Heyne, H., Tönjes, A., Schleinitz, D., Ihling, C. H., Stumvoll, M., Freire, R., Fiorentino, M., Fasano, A., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00022 · Cited by 163
“Indeed, numerous studies in mouse models have demonstrated that changes in the gut microbiota can alter the gut permeability and lead to an endotoxemia-induced inflammation in adipose tissue, and ultimately to obesity (3, 8, 9).”
Background
Metadata
- Authors
- Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R.
- Affiliations
- UCLouvain (BE)
- Nestlé (Switzerland) (CH)
- Rangueil Institute of Molecular Medicine, Toulouse, France
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-06-01
- Volume
- 57
- Issue
- 6
- Pages
- 1470-1481
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2129917444
- Cited by
- 4,819
- References
- 47
- Citations by year
- 2026: 223 · 2025: 240 · 2024: 305 · 2023: 319 · 2022: 397 · 2021: 420 · 2020: 389 · 2019: 396 · 2018: 368 · 2017: 319 · 2016: 319 · 2015: 292 · 2014: 199 · 2013: 187 · 2012: 149
- FWCI
- 40.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Digital Access to Libraries (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-PNRA-004, ANR-05)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut microbiota, metabolic endotoxemia, lipopolysaccharide, high-fat diet, obesity, type 2 diabetes, low-grade inflammation, antibiotic therapy, intestinal permeability, tight junctions, CD14, visceral adipose tissue, oxidative stress, impaired glucose tolerance, ob/ob mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteroides, Base Sequence, Bifidobacterium, Cecum, Crosses, Genetic, Diabetes Mellitus, Experimental, Feces, Female, Genotype, Inflammation, Lactobacillus, Male, Mice, Inbred C57BL, Mice, Obese, Obesity, RNA, Bacterial, Endotoxemia, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.